Navigation Links
OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer
Date:5/30/2008

PORTLAND, Ore. Men with a certain type of prostate cancer have been shown to respond to a new chemotherapy drug, Sagopilone, plus prednisone in an international trial led by Oregon Health & Science University Cancer Institute researchers.

The research involved men with androgen-independent prostate cancer that has metastasized, meaning their cancer has spread beyond the prostate and is not longer responding to hormonal therapies. This is the most advanced form of prostate cancer. Prostate cancer is the most common type of cancer in men in the United States, where it is responsible for more male deaths than any other cancer, except lung cancer.

"We are showing solid activity that this drug shows promise," said Tomasz Beer, M.D., principal investigator. He is the Grover C. Bagby Endowed Chair for Cancer Research, director of the Prostate Cancer Research Program at the OHSU Cancer Institute and associate professor of medicine (hematology/medical oncology), OHSU School of Medicine.

This research will be presented Saturday, May 31 at 8 a.m. at the annual American Association of Clinical Oncology in Chicago.

Of the 37 study participants taking the Sagopilone and prednisone long enough to be evaluated, the majority showed positive results in the reduction of their prostate specific antigens, or PSA. PSA is often elevated in the presence of prostate cancer.

During the three-month trial thirteen study participants had a more than 50 percent reduction in their PSA; 23 showed a 30 percent reduction; one who had radiographic measurable disease showed complete response; and four had unconfirmed prostate response. A 30 percent reduction in PSA levels in three months is a strong indicator of survival.

Sagopilone, a fully synthetic derivation, is a new class of drug that inhibits growth and the spread of malignant cell, similar to docetaxel, which has been the gold standard for this type of hormone independent prost
'/>"/>

Contact: Christine Decker
deckerch@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 Recognizing ... International Plant-based Nutrition Healthcare Conference announced today ... enrolled in studies of medicine or a healthcare-related field, ... advantage of special student-only discounts for the conference, scheduled ... the Loews Coronado Bay Resort. , “As ...
(Date:7/31/2014)... Many lawyers take up the law for ... injustices, and preserve the rule of law. Upholding these values ... as crusading and exemplary by some, but reckless and inconvenient ... seed might be planted within the legal system itself, the ... for an attorney - a referral to the bar's disciplinary ...
(Date:7/31/2014)... Angeles, CA (PRWEB) July 31, 2014 Staying ... can be tricky at best. Men and women get sucked ... husbands, wives, life partners, and taxi services to kids. ... Black, offers her "3 Fast + Fun Ways to Reignite ... free download . , “This is a much better ...
(Date:7/31/2014)... but no matter how hard you hit, your opponent ... said of highly treatment-resistant cancers, such as head and ... cells repair themselves, survive and thrive. Head and neck ... world, but the late detection and treatment resistance result ... of Michigan researchers have found that a particular proteinTRIP13encourages ...
(Date:7/31/2014)... Updox, the industry leader for ... release of a “Twelve Questions to Ask When Selecting a ... evaluating Health Information Service Providers (HISPs) for Direct Messaging to ... and Epic electronic health records (EHRs) need to separately contract ... using the Direct protocol. , “Selecting a HISP ...
Breaking Medicine News(10 mins):Health News:Student Discounts Offered for International Plant-based Nutrition Healthcare Conference 2Health News:Student Discounts Offered for International Plant-based Nutrition Healthcare Conference 3Health News:Supreme Court Press Petition of the Month for July 2014: Shutting Down Inconvenient Lawyers By Disbarment or Suspension 2Health News:Supreme Court Press Petition of the Month for July 2014: Shutting Down Inconvenient Lawyers By Disbarment or Suspension 3Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 2Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 3Health News:Updox Introduces Resources to Help Hospitals Choose the Right HISP for Direct Messaging 2Health News:Updox Introduces Resources to Help Hospitals Choose the Right HISP for Direct Messaging 3Health News:Updox Introduces Resources to Help Hospitals Choose the Right HISP for Direct Messaging 4
... , WASHINGTON, July 31 Speaker Nancy Pelosi issued ... and Commerce Committee to pass the America,s Affordable Health Choices Act, ... The House Ways and Means Committee and Education and Labor Committee ... "For more than 60 years, we have tried as a ...
... , , PHOENIX, July 31 ... of Columbus are gathering for their 127th annual convention, to be held ... in Phoenix, Arizona. The Knights of Columbus, founded in 1882, is ... 11 countries on three continents. , , In addition ...
... , , WASHINGTON, July 31 ... will be held in Copan Ruinas, Honduras on September 24-26, ... of over 110 medical brigades, universities, churches, hospitals, civic clubs ... companies involved in volunteer work in Honduras. , , ...
... cancer neuroblastoma are eight times more likely to have ... more likely to have lower incomes than their siblings, ... the Journal of the National Cancer Institute . ... on the long-term outcomes for neuroblastoma survivors. Caroline ...
... WASHINGTON, July 31 After adding abortion coverage and funding ... 3200, the Energy and Commerce Committee today rejected an amendment ... provide abortion coverage. Family Research Council President Tony Perkins ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO ) , ...
... , , , , ... Corp. (OTC Bulletin Board: BBVUF, BBVVF and BBVWF) (the "Company") announced ... Migami, Inc. to enter into a business combination. Pursuant to ... has until February 13, 2010 to complete the business combination. If ...
Cached Medicine News:Health News:Knights of Columbus Gather in Phoenix for 127th International Convention 2Health News:Conference on Honduras 2009 Set for Copan Ruinas 2Health News:Long-term health and social outcomes for neuroblastoma survivors 2Health News:Once Again, House Rejects Amendment Preventing Taxpayer Funding for Abortion 2Health News:BBV Vietnam S.E.A. Acquisition Corp. Announces Signing of Letter of Intent for Business Combination with Migami, Inc. 2
(Date:7/31/2014)... Laboratories, Inc. (Nasdaq: CBRX ) ("Columbia" ... the three and six-month periods ended June 30, ... from the contribution of the Molecular Profiles services ... an anticipated and temporary decline in product revenues ... in one high-volume, high-margin market. Throughout the renewal ...
(Date:7/31/2014)... 31, 2014 Auxilium Pharmaceuticals, Inc. ... biopharmaceutical company, today announced that the Company will ... its partner Asahi Kasei Pharma Corporation (Asahi Kasei). ... submission of a regulatory application to the Japanese ... ® (collagenase clostridium histolyticum) for the treatment ...
(Date:7/30/2014)...  There is still time to share your ... Annual Institute for Supply Management ® – ... Management is open for submissions.  The annual competition ... of supply management by recognizing supply management organizations ... practices.  Entries are due August 22, 2014. ...
Breaking Medicine Technology:Columbia Laboratories Reports Second Quarter 2014 Financial Results 2Columbia Laboratories Reports Second Quarter 2014 Financial Results 3Columbia Laboratories Reports Second Quarter 2014 Financial Results 4Columbia Laboratories Reports Second Quarter 2014 Financial Results 5Columbia Laboratories Reports Second Quarter 2014 Financial Results 6Columbia Laboratories Reports Second Quarter 2014 Financial Results 7Columbia Laboratories Reports Second Quarter 2014 Financial Results 8Columbia Laboratories Reports Second Quarter 2014 Financial Results 9Columbia Laboratories Reports Second Quarter 2014 Financial Results 10Columbia Laboratories Reports Second Quarter 2014 Financial Results 11Columbia Laboratories Reports Second Quarter 2014 Financial Results 12Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices 2
... EAST BRUNSWICK, N.J., Oct. 25 Savient Pharmaceuticals, Inc. (Nasdaq: ... host a conference call on Tuesday, October 26, 2010 at ... detail around its KRYSTEXXA™ launch plans. ... will host a live conference call on October 26, 2010 ...
... The National Community Pharmacists Association (NCPA) today announced ... by Cardinal Health , which found that independent community ... in 2009 despite a stagnant economy, the growing influence ... and the questionable business practices of pharmacy benefit managers ...
Cached Medicine Technology:Savient Pharmaceuticals to Hold Conference Call on October 26, 2010 at 8:30 a.m. Eastern Time 2Savient Pharmaceuticals to Hold Conference Call on October 26, 2010 at 8:30 a.m. Eastern Time 3NCPA Digest Finds Independent Community Pharmacies Stable Despite Economic, Third-Party Challenges 2NCPA Digest Finds Independent Community Pharmacies Stable Despite Economic, Third-Party Challenges 3NCPA Digest Finds Independent Community Pharmacies Stable Despite Economic, Third-Party Challenges 4
... CEQ 8000 is a fully automated genetic ... capillary array with a patented linear polyacrylamide ... applies the voltage program, and analyzes the ... data quality and even customize automated data ...
Basic critical care testing. Measures pH, pCO2, and pO2 from 85 L whole-blood sample....
... parameters from just 95 L of ... as well as any combination of ... Unique technology reduces to a minimum ... on the accuracy of blood gas, ...
348 is fully automated blood gas systems offering a cost-effective solution for critical care testing in settings with low to medium workloads....
Medicine Products: